Logistics firms invest millions to expand cold chain facilities amid rising demand for temperature-sensitive drugs like GLP-1s.
· Source: pluang.com
In short
Shipping and logistics companies including UPS, FedEx, DHL, and C.H. Robinson are investing heavily in temperature-controlled facilities to meet the rising demand for shipping specialized pharmaceuticals such as GLP-1 weight loss drugs. These medications require strict refrigerated storage, driving logistics firms to enhance their cold chain infrastructure and technology. The healthcare logistics sector is rapidly expanding, with UPS reporting a $3 billion healthcare revenue quarter and FedEx nearing $10 billion in healthcare transportation revenue.
Read Original Article — Read the full article on the publisher’s site.
In the issue of week 30, 2026: AI Integration Drives Real-Time Gains in Supply Chain Execution and Productivity
Tags: cold chain, logistics, pharmaceuticals, healthcare, GLP-1, supply chain